Affiliation:
1. Azadi Teaching Hospital, Iraq Board for Medical Specialization, Kirkuk, Iraq
2. Department of Obstetrics and Gynaecology, College of Medicine, University of Kirkuk, Kirkuk, Iraq
Abstract
Abstract
Background:
Pregnant women are often iron deficient, and this has adverse effects on thyroid metabolism. Impaired maternal thyroid function in pregnancy may cause neurodevelopmental delay in the offspring.
Objectives:
To investigate if maternal iron status is a determinant of thyroid stimulating hormone (TSH) and/or free T4 (FT4) concentrations during pregnancy.
Materials and Methods:
A case–control study was conducted in the Department of Obstetrics and Gynecology at Azadi Teaching Hospital, Kirkuk, Iraq over a period of 7 months from February 1st to September 1st, 2020. It included 80 pregnant women with singleton pregnancy in the obstetric outpatient clinic and labor room. Verbal consent was obtained. They were divided into: (1) case group: it included 40 cases of iron deficiency (ID) anemic pregnant women with hemoglobin level of 105 g/L and less in the second and third trimesters. (2) Control group: It included 40 cases of healthy pregnant women. Estimation of gestational age was done depending on the date of last menstrual cycle, and/or early ultrasound scan.
Results:
In this study, 80 pregnant women in their second and third trimesters participated. Fifty percent were anemic, had elevated serum soluble transferrin receptor and negative body iron stores, 35% had a free T4 less than 7.5 pmol/L, and 47.5% had a TSH more than 4.0 mIU/L. 47.5% who were hypothyroid had negative body iron store. Serum ferritin, soluble transferrin receptor, and body iron stores were highly significant predictors of thyroid status.
Conclusions:
Poor maternal iron status predicts both higher TSH and lower free T4 concentrations during pregnancy. On the basis of results, we had there may be a correlation between ID anemia of pregnant women and their thyroid status.